Home > Insider Trading > Filing (0001209191-13-058265)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
858803	Avanir Pharmaceuticals Inc.	AVNR	Pharmaceutical Preparations (2834)	330314804

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1534986	Md Joao Siffert	20 Enterprise, Suite 200 Aliso Viejo CA 92656	Svp, R&D	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2013-12-18	5,970	$2.63	110,230	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. The proceeds from the sales will be used to pay required withholdings due by the Reporting Person upon the vesting of 12,282 Restricted Stock Units on December 17, 2013. Following the sales reported on this Form 4, the Reporting Person has a total of 172,031 options to purchase shares of common stock that are vested and immediately exercisable and a total of 245,625 options to purchase shares of common stock that have not yet vested. Following the sales reported on this Form 4, the Reporting Person also has 214,225 unvested Restricted Stock Units, of which 43,000 are performance-based Restricted Stock Units.
Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting Person, which are subject to certain vesting conditions.